INAPPROPRIATE S-ICD PATIENT RECEIVES FALSE POSITIVE SHOCKS


Autoři: David Korpas
Působiště autorů: Institute of Nursing, Faculty of Public Policies, Silesian University, Opava, Czech Republic
Vyšlo v časopise: Lékař a technika - Clinician and Technology No. 2, 2020, 50, 69-72
Kategorie: Původní práce
doi: 10.14311/CTJ.2020.2.05

Souhrn

Subcutaneous implantable cardioverter defibrillator (S-ICD) protects the patients at risk for sudden cardiac death while leaving the heart and vasculature untouched. It provides life-saving therapy, but may also deliver inappropriate therapy. Presented case demonstrates a possibility of S-ICD therapy induction due to double-counting. It was original caused by lack of suitable sensing vectors and the solution was possible just particularly. As the inter-individual variability of subcutaneous cardiac signal is considerable, the patient screening should be necessary for identification of such patients, which have an unsuitable subcutaneous sensing signals.

Klíčová slova:

false-positive therapy – defibrillation – implantable cardioverter-defibrillator – patient screening


Zdroje
  1. Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, et al. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation. 2013 Aug 27;128(9): 944–53. DOI: 10.1161/CIRCULATIONAHA.113.003042
  2. Boston Scientific. User’s manual EMBLEM™ S-ICD, EMBLEM™ MRI S-ICD.
    https://www.bostonscientific.com/content/dam/bostonscientific/Rhythm%20Management/portfolio-group/EMBLEM_S-ICD/Download_Center/359481-001%20EMBLEM%20S-ICD%20PTM_English.pdf (22nd June 2019 date last accessed)
  3. Gold MR, Theuns DA, Knight BP, Sturdivant JL, Sanghera R, Ellenbogen KA, et al. Head-to-Head Comparison of Arrhyth-mia Discrimination Performance of Subcutaneous and Transve-nous ICD Arrhythmia Detection Algorithms: The START Study. Journal of Cardiovascular Electrophysiology. 2011 Oct 28;23(4):359–66. DOI: 10.1111/j.1540-8167.2011.02199.x
  4. Bellardine Black CL, Stromberg K, Van Balen GP, Ghanem RN, Breedveld RW, Tieleman RG. Is surface ECG a useful surrogate for subcutaneous ECG? Pacing Clin Electrophysiol. 2010 Jan 24;33(2):135–45. DOI:
    10.1111/j.1540-8159.2009.02616.x
  5. Zeb M, Curzen N, Veldtman G, Yue A, Roberts P, Wilson D, et al. Potential eligibility of congenital heart disease patients for subcutaneous implantable cardioverter-defibrillator based on surface electrocardiogram mapping. Europace. 2015 Feb 12; 17(7),1059–67. DOI: 10.1093/europace/euu375
  6. Ali H, Lupo P, Cappato R. The Entirely Subcutaneous Defibril-lator – A New Generation and Future Expectations. Arrhythmia & Electrophysiology Review. 2015 Aug;4(2):116–21. DOI: 10.15420/aer.2015.04.02.116
Štítky
Biomedicína
Kurzy Podcasty Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Nemáte účet?  Registrujte se

Zapomenuté heslo

Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se